Pictet Asset Management’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,047
Closed -$52.7K 2082
2025
Q3
$52.7K Hold
2,047
﹤0.01% 2023
2025
Q2
$118K Buy
2,047
+607
+42% +$48.7K ﹤0.01% 1916
2025
Q1
$156K Hold
1,440
﹤0.01% 1847
2024
Q4
$68.4K Hold
1,440
﹤0.01% 2005
2024
Q3
$141K Hold
1,440
﹤0.01% 1901
2024
Q2
$235K Hold
1,440
﹤0.01% 1680
2024
Q1
$220K Hold
1,440
﹤0.01% 1725
2023
Q4
$452K Hold
1,440
﹤0.01% 1328
2023
Q3
$639K Buy
+1,440
New +$651K ﹤0.01% 1115

Other funds holding AGL

Pictet Asset Management's AGL Position: Q4 2025 in Review

Pictet Asset Management sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 2,047 shares — an estimated $52.7K sold.

Pictet Asset Management first reported a position in AGL in Q3 2023 and held it in 9 quarters. The position peaked at $639K in Q3 2023. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • Pictet Asset Management reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • Pictet Asset Management sold 2,047 Agilon Health shares in Q4 2025, an estimated $52.7K.
  • Pictet Asset Management first reported a position in Agilon Health in Q3 2023 and held it in 9 quarters.
  • Pictet Asset Management's Agilon Health position peaked at $639K in Q3 2023.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Pictet Asset Management's 13F filing for Q4 2025, filed 29 Jan 2026.